Physician

Matthew Robert Paszek, MD

According to 2025 Medicare claims, Matthew Paszek, MD (NPI: 1346403870) practices urology in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is UNC PHYSICIANS NETWORK LLC (NPI: 1558786830; TIN: 271081647) and primary practice location at 27804-2417. Paszek is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Paszek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 804 traditional Medicare patients, billed 4,446 HCPCS/CPT codes, and received $213,833 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,324 prescription claims across 894 beneficiaries totaling $233,921 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 62 claims. Open Payments data shows 6 records totaling $347. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $307,599 to $213,833. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and declined steadily, from $1,175 to $185.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,260	9,140	$307,599
2016	1,323	11,847	$317,511
2017	1,170	10,252	$332,283
2018	1,025	8,092	$276,918
2019	1,352	10,629	$383,740
2020	1,158	8,891	$322,453
2021	1,131	6,222	$312,208
2022	961	5,376	$260,631
2023	856	4,500	$220,957
2024	804	4,446	$213,833

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	589	2,924	$182,134
2016	642	3,594	$236,938
2017	648	3,711	$261,995
2018	662	3,567	$275,394
2019	814	3,665	$302,756
2020	857	4,326	$453,332
2021	886	3,946	$418,311
2022	891	4,256	$384,800
2023	903	4,323	$292,467
2024	894	4,324	$233,921

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	82	$16,040
2016	N/R	126	$9,385
2017	N/R	164	$9,627
2018	N/R	172	$10,389
2019	N/R	148	$11,629
2020	11	184	$13,619
2021	N/R	195	$12,757
2022	N/R	150	$10,289
2023	N/R	153	$12,646
2024	N/R	62	$11,492

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	535	801	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	332	478	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	242	256	$9
51798	Ultrasound measurement of bladder capacity after voiding	286	358	$7
81001	Manual urinalysis test with examination using microscope, automated	676	1,126	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	160	7,695	$115,521
Gemtesa	Vibegron	56	2,250	$36,709
Tamsulosin Hcl	Tamsulosin Hcl	1,485	104,868	$19,737
Potassium Citrate Er	Potassium Citrate	131	6,441	$9,686
Finasteride	Finasteride	742	56,876	$9,022

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	25	$10,901
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	14	$277
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	11	$239
A4402	Lubricant, per ounce	N	N/R	12	$75

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$347	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Robert Paszek, MD?

Tedicare shows public-source Medicare data for Matthew Robert Paszek, MD (NPI 1346403870), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Robert Paszek, MD have ACO affiliation data?

Matthew Robert Paszek, MD is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Matthew Robert Paszek, MD?

Matthew Robert Paszek, MD is linked to UNC PHYSICIANS NETWORK LLC (billing NPI 1558786830) in the available physician profile data.

Does Matthew Robert Paszek, MD have Open Payments data?

Matthew Robert Paszek, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.